Product Images Rituxan Hycela

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Rituxan Hycela NDC 50242-108 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PRINCIPAL DISPLAY PANEL - 11.7 mL Vial Carton - rituxan 01

PRINCIPAL DISPLAY PANEL - 11.7 mL Vial Carton - rituxan 01

Rituxan Hycela is a medication that is administered via subcutaneous injection over 5 to 7 minutes, using a single-dose vial. It contains both rituximab and hyaluronidase human, with a strength of 1,400 mg and 23,400 Units/11.7 mL (120mg and 2,000 Units/mL). This medication is intended for subcutaneous use only and any unused portion should be discarded. Pharmacies should dispense the accompanying medication guide to patients who are prescribed this medication.*

PRINCIPAL DISPLAY PANEL - 13.4 mL Vial Carton - rituxan 02

PRINCIPAL DISPLAY PANEL - 13.4 mL Vial Carton - rituxan 02

Rituxan Hycela is a medication that contains rituximab and hyaluronidase human, used for subcutaneous injection only. It comes in a single-dose vial containing 1,600 mg and 26,800 Units/13.4 mL (120 mg and 2,000 Units/mL). It should be administered over 5 to 7 minutes, and any unused portion should be discarded. Pharmacists are advised to dispense the accompanying Medication Guide to each patient. Manufactured by Genentech | ®Biogene. NDC 50242-109-0.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.